Emergent BioSolutions Inc. (NYSE:EBS) is one of the Best Performing Affordable Stocks Under $40. On January 8, Emergent ...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article ...

Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...

New York AG Tish James sued former Emergent BioSolutions CEO over alleged insider trading around the COVID vaccine.

Letitia James accused Robert Kramer of selling his shares in Emergent before disclosing contamination issues in its ...

Detailed price information for Emergent Biosolutions (EBS-N) from The Globe and Mail including charting and trades.

Detailed price information for Emergent Biosolutions (EBS-N) from The Globe and Mail including charting and trades.

Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with ...

The former CEO of Emergent BioSolutions was accused of insider trading by the New York attorney general in connection with a ...

GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions, Inc. (NYSE: EBS) announced it made a voluntary prepayment of $100 million under its outstanding term loan facility in ...

Since the U.S. prescription launch of NARCAN® Nasal Spray in 2016, the medicine has been trusted as a safe, effective way to reverse opioid ...

New York Attorney General sued the former CEO of Emergent BioSolutions, Robert G. Kramer, for insider trading.